These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30863458)

  • 1. The Cost-Effectiveness Analysis and Optimal Strategy of the Tobacco Control.
    Pang L; Liu S; Zhang X; Tian T
    Comput Math Methods Med; 2019; 2019():8189270. PubMed ID: 30863458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study.
    Feenstra TL; Hamberg-van Reenen HH; Hoogenveen RT; Rutten-van Mölken MP
    Value Health; 2005; 8(3):178-90. PubMed ID: 15877590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost effectiveness of full coverage of the medical management of smoking cessation in France.
    Chevreul K; Cadier B; Durand-Zaleski I; Chan E; Thomas D
    Tob Control; 2014 May; 23(3):223-30. PubMed ID: 23197369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of "small" effects of smoking cessation treatments.
    West R
    Addiction; 2007 Apr; 102(4):506-9. PubMed ID: 17362283
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America.
    Pichon-Riviere A; Augustovski F; Bardach A; Colantonio L;
    Value Health; 2011; 14(5 Suppl 1):S51-9. PubMed ID: 21839900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cost-effectiveness analysis of online, radio and print tobacco control advertisements targeting 25-39 year-old males.
    Clayforth C; Pettigrew S; Mooney K; Lansdorp-Vogelaar I; Rosenberg M; Slevin T
    Aust N Z J Public Health; 2014 Jun; 38(3):270-4. PubMed ID: 24750454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective tobacco dependence treatment.
    Fiore MC; Hatsukami DK; Baker TB
    JAMA; 2002 Oct; 288(14):1768-71. PubMed ID: 12365962
    [No Abstract]   [Full Text] [Related]  

  • 9. Mass media interventions for smoking cessation in adults.
    Bala M; Strzeszynski L; Cahill K
    Cochrane Database Syst Rev; 2008 Jan; (1):CD004704. PubMed ID: 18254058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An appraisal of smoking cessation aids.
    Mundey K
    Curr Opin Pulm Med; 2009 Mar; 15(2):105-12. PubMed ID: 19532024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Healthcare financing systems for increasing the use of tobacco dependence treatment.
    Kaper J; Wagena EJ; Severens JL; Van Schayck CP
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004305. PubMed ID: 15674938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tobacco dependence treatment guidelines].
    Králíková E; Češka R; Pánková A; Štěpánková L; Zvolská K; Felbrová V; Kulovaná S; Zvolský M
    Vnitr Lek; 2015 May; 61(5 Suppl 1):1S4-1S15. PubMed ID: 26955915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of a very brief smoking-reduction intervention in smokers who have no intention to quit: study protocol for a randomized controlled trial.
    Wu L; He Y; Jiang B; Zhang D; Tian H; Zuo F; Lam TH; Cheung YT
    BMC Public Health; 2015 Apr; 15():418. PubMed ID: 25944023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smoking cessation should have more emphasis within Tobacco Control? The case for.
    Bolliger CT
    Health Policy; 2009 Jul; 91 Suppl 1():S31-6. PubMed ID: 19735856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Methods and cost effectiveness of nicotine abstinence].
    Górecka D
    Pol Merkur Lekarski; 2004 May; 16 Suppl 1():79-82. PubMed ID: 15524024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Effectiveness of Post-Discharge Strategies for Hospitalized Smokers: study protocol for the Helping HAND 2 randomized controlled trial.
    Reid ZZ; Regan S; Kelley JH; Streck JM; Ylioja T; Tindle HA; Chang Y; Levy DE; Park ER; Singer DE; Carpenter KM; Reyen M; Rigotti NA
    BMC Public Health; 2015 Feb; 15():109. PubMed ID: 25879193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare financing systems for increasing the use of tobacco dependence treatment.
    Reda AA; Kaper J; Fikrelter H; Severens JL; van Schayck CP
    Cochrane Database Syst Rev; 2009 Apr; (2):CD004305. PubMed ID: 19370599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost-effectiveness of call-back counselling for smoking cessation.
    Lal A; Mihalopoulos C; Wallace A; Vos T
    Tob Control; 2014 Sep; 23(5):437-42. PubMed ID: 23748188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. III. Maternal smoking cessation: a cost effective strategy for managed care. Introduction.
    Barker DC
    Tob Control; 2000; 9 Suppl 1(Suppl 1):I60. PubMed ID: 10688942
    [No Abstract]   [Full Text] [Related]  

  • 20. [Health insurance coverage for smoking cessation treatment in Japan: current status and future issues].
    Nakamura M
    Nihon Rinsho; 2013 Mar; 71(3):499-505. PubMed ID: 23631243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.